Acquisitions16 Jun 2026, 02:49 pm
Marksans Pharma Completes QliniQ B.V. Acquisition
AI Summary
Marksans Pharma Limited has successfully completed the acquisition of 100% share capital of QliniQ B.V., a Netherlands-based entity. This follows a prior intimation on June 1, 2026, and marks the finalization of the acquisition process. The company has officially recorded the completion of this strategic move.
Key Highlights
- Marksans Pharma has acquired 100% of QliniQ B.V.
- The acquired entity is based in the Netherlands.
- The acquisition process has now been fully completed.
- This is a significant strategic move for the company.
Price Impact
More from MARKSANS
More in Acquisitions